AzTrials
AzTrials

ObesityPhase 2NCT00069732

Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss

A Phase 2 study testing qigong and acupressure-TAT in people with Obesity, run by Kaiser Permanente at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
qigong and acupressure-TAT
How many people
90 participants
Where
1 siteUnited States
Study dates
Start not givento not given
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • BMI 25-35 kg/m 2
  • Reside in Portland metropolitan area
  • Willing to complete the 12-week weight loss program
  • Willing to accept random assignment to one of the three maintenance treatment conditions
  • Willing to provide informed consent

Who cannot join

  • Medical conditions or treatments that would be contraindicated using a diet \& exercise weight loss treatment
  • Cancer
  • Significant GI disease inappropriate for diet and physical activity intervention
  • Diabetes dependent on insulin or oral hypoglycemic medications
  • Psychiatric hospitalization in past 2 years
  • Conditions that require limitation of physical activity
Show all 19Show fewer
  • Congestive Heart Failure
  • Cardiovascular Disease (stroke, MI, CABG, ASCVD)
  • Taking weight loss medications currently or within past 6 months
  • Previous history of complementary or alternative medicine (CAM) weight loss treatment
  • Current acupressure, or Qi Gong, or acupuncture
  • Reported consumption of more than 21 alcoholic drinks per week
  • Planning to leave the area prior to the end of the program
  • Body weight change > 10 pounds in the 6 months prior to Screening visit one
  • Pregnant, breast feeding, or planning pregnancy prior to the end of participation
  • Current participation in another clinical trial
  • Investigator discretion for safety or adherence reasons
  • Household member of another CAM WT participant
  • Unavailable for group sessions

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Center for Health Research

    Portland, Oregon

Other trials in United States

About this study

Official title: Pilot of Two CAM Treatments for Maintenance of Weight Loss

The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss.

Read the detailed description

The prevalence of obesity is at epidemic proportions, 60% of US adults are overweight or obese. Obesity contributes to chronic diseases (diabetes, cardiovascular disease [CVD], hypertension, cancer, and osteoarthritis) and to escalating health care costs. Weight loss can have a substantial impact on reducing these conditions. Substantial efforts have been made in developing effective short-term weight loss programs using behavioral treatments. However, long-term maintenance of weight loss continues to be problematic - many individuals regain the weight lost within a year. Innovative intervention options are critically needed to help people successfully maintain weight loss and to fight the obesity epidemic. Complementary and alternative medicine (CAM) approaches-mind-body, energy healing, and Traditional Chinese Medicine (TCM) approaches may hold great promise for helping improve the maintenance of weight loss.

Conditions
Obesity
Being tested
qigong, acupressure-TAT
Keywords
Overweight, Weight loss maintenance, CAM therapy, Qigong, Acupressure, Traditional Chinese Medicine
Medical subject headings
Obesity, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • qigongBehavioural

  • acupressure-TATBehavioural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2003 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00069732
Sponsor's protocol ID
R21AT001190-01A1
Other IDs
R21AT001190-01A1
Status last verified
Feb 2010
First submitted
30 Sep 2003
Last updated
12 Feb 2010
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing qigong and acupressure-TAT in people with Obesity, run by Kaiser Permanente at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 12 Feb 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early. Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in